Related Experiment Video
Updated: Jul 17, 2026

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
[Mumps in Poland in 2004]
1Zakład Epidemiologii Pańistwowego Zakładu Higieny, Warszawa. pstefanoff@pzh.gov.pl
Abstract:
In 2004, 135,179 cases of mumps were reported in Poland. The incidence (354.1 per 100,000) was higher compared to 2003 (228.7) and to the median incidence in 1999-2002 (75.0). The increase of mumps incidence in 2004 corresponds to natural fluctuations in the epidemic cycle, it is however delayed and lower compared to the previous peaks. This prolongation of epidemic cycle can be attributed to increasing vaccine coverage among 3 year old children (from 16.7% in 1999 to 48.5% in 2004). Mandatory vaccination of children aged 13-14 months with trivalent measles-mumps-rubella vaccine was implemented at the beginning of 2004. Approximately 4.5% of cases were hospitalized (6,019) and no deaths attributed to mumps were reported. Children 5-9 year old were the most affected age group (incidence 3,110.5 per 100,000).
Insights
In 2004, Poland saw a significant rise in mumps cases, with incidence increasing due to natural epidemic cycles. Rising measles-mumps-rubella (MMR) vaccine coverage in young children may be influencing the prolonged and delayed epidemic pattern.
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Context:
- Mumps incidence in Poland significantly increased in 2004 compared to previous years.
- The 2004 mumps epidemic showed a delayed and lower peak than historical patterns.
- Vaccine coverage for measles-mumps-rubella (MMR) in 3-year-olds rose substantially from 1999 to 2004.
Purpose:
- To analyze the mumps epidemic trends in Poland in 2004.
- To investigate the potential impact of increasing MMR vaccination rates on mumps epidemiology.
- To identify the most affected age groups during the 2004 mumps outbreak.
Summary:
- Poland reported 135,179 mumps cases in 2004, with an incidence of 354.1 per 100,000.
- The increase aligns with epidemic cycles but is delayed and less pronounced than previous peaks, potentially due to rising MMR vaccination coverage.
- Children aged 5-9 years were most affected; 4.5% of cases required hospitalization, with no reported deaths.
Impact:
- Highlights the dynamic nature of infectious disease outbreaks and their response to vaccination campaigns.
- Provides data on the effectiveness of MMR vaccination in modulating epidemic cycles.
- Informs public health strategies for mumps prevention and control, particularly in pediatric populations.
Related Concept Videos
Poliomyelitis
Chickenpox
Smallpox
Viral Meningitis
Atypical Pneumonia
Vaccinations

